Tetavax, suspenzija za injekciju u napunjenoj štrcaljki, cjepivo protiv tetanusa, adsorbirano
| Name | Tetavax, suspenzija za injekciju u napunjenoj štrcaljki, cjepivo protiv tetanusa, adsorbirano |
|---|---|
| Marketing Authorisation Number | HR-H-943015948 |
| Active Substance | toksoid tetanusa |
| Composition | jedna doza (0,5 ml) sadrži: Toksoid tetanusa ≥ 40 IU adsorbiran na aluminijev hidroksid, hidrirani 0,6 mg Al |
| Pharmaceutical Form | suspenzija za injekciju u napunjenoj štrcaljki |
| Manufacturer | Sanofi-Aventis Zrt., Budimpešta, Mađarska Sanofi Pasteur, Lyon, Francuska |
| Marketing Authorisation Holder | Sanofi Winthrop Industrie, 82, avenue Raspail, Gentilly, Francuska |
| Marketing Authorisation Date | 24.12.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/638 |
| Registration Number | 381-12-01/171-24-39 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | J07AM01 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
